Hollie Bulfin, Author at

Decipher Complement Pathway Intricacies, Validate Pathway Activation Assays & Discover Next-Generation Complement-Targeted Approaches that are Transforming Patient Outcomes

Welcome to the 6th Complement-based Drug Development Summit 2022

https://pharmaphorum.com/events/welcome-to-the-6th-complement-based-drug-development-summit-2022/

Events/ Events/ R&D

Welcome to the 2nd Chronic HBV Drug Development Summit

Hollie Bulfin HBV, HepatitisB, hepatology, vaccine, virology

Advance Combination Therapies, Outline Clinical Endpoints & Understand the Immunology Perspective to Achieve Functional Cures for Chronic Hepatitis

Welcome to the 2nd Chronic HBV Drug Development Summit

https://pharmaphorum.com/events/welcome-to-the-2nd-chronic-hbv-drug-development-summit/

Events/ Events/ Oncology

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

Hollie Bulfin cancer, immuno-oncology, myeloid biology, Oncology, tumor microenvironment 0 Comment

Identify, Validate, & Clinically Develop Novel Targets to Modulate Myeloid Cells & Overcome Solid Tumor Barriers Returning in

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

https://pharmaphorum.com/events/welcome-to-the-2nd-tumor-myeloid-directed-therapies-summit/

Trending

About Hollie Bulfin

Posts by Hollie Bulfin:

Welcome to the 6th Complement-based Drug Development Summit 2022

Welcome to the 2nd Chronic HBV Drug Development Summit

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

Trending

About Hollie Bulfin

Posts by Hollie Bulfin:

Login